Sandra and Edward Meyer Cancer Center

You are here

Calendar

All Events

The Meyer Cancer Center Cancer Biology Research Program presents: Barry Sleckman, M.D., Ph.D. Professor of Pathology and Laboratory Medicine Associate Director of Shared Resources Meyer Cancer Center Weill Cornell Medicine
4:00pm to 7:00pm
Weill Cornell Medicine Belfer Research Building, Room 302 C/D
The Meyer Cancer Center Solid Tumors Research Program presents: Olivier Elemento, Ph.D. Director, Englander Institute for Precision Medicine Associate Professor of Physiology and Biophysics Associate Professor of Computational Genomics in Computational Biomedicine Walter B. Wriston Research Scholar Program Co-Leader, Cancer Genetics, Epigenetics & Systems Biology Research Program, Meyer Cancer Center Weill Cornell Medicine
5:30pm to 7:00pm
Belfer Research Building 204 A/B
Marcus DaSilva Goncalves, M.D., Ph.D. Lecturer, Biochemistry, Cell & Developmental Biology Assistant Professor, Department of Medicine Weill Cornell Medicine Host: Dr. Frederick Maxfield
12:00pm to 1:00pm
Weill Cornell Medical College A106
The Meyer Cancer Center Seminar Series presents: Maria "Ken" Figueroa, M.D. Associate Professor of Human Genetics Co-Leader, Cancer Epigenetics Program Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine
4:00pm to 7:00pm
Belfer Research Building Belfer Research Building, 204 A/B/C
The Meyer Cancer Center Cancer Genetics, Epigenetics & Systems Biology (CGESB) Research Program presents: Juan Cubillos-Ruiz, Ph.D. William J. Ledger, M.D. Distinguished Assistant Professor for Infection and Immunology in Obstetrics and Gynecology Weill Cornell Medicine
5:00pm to 7:00pm
Belfer Research Building 302A
The Meyer Cancer Center Immuno-Oncology Working Group presents: Kristen Radford, Ph.D. Principal Research Fellow Mater Research, The University of Queensland
12:00pm to 1:00pm
Belfer Research Building Room 1301
Biochemistry and Cell & Developmental Biology Lecturer: Andrew Stewart, M.D. Director, Diabetes Obesity and Metabolism Institute Professor, Dept. of Medicine Icahn School of Medicine at Mount Sinai
12:00pm to 1:00pm
WCM A106
Join us on October 17-20, 2018 for the 18th annual Lymphoma & Myeloma Congress. This program features four days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders. Target Audience This educational activity is designed for domestic and international healthcare clinicians, including hematologists and hematologic oncologists, medical, radiation, and surgical oncologists, and other healthcare professionals (physicians, physicians-in-training, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) who are involved and/or interested in the treatment of patients with hematologic malignancies. Learning Objectives Upon successful completion of these educational activities, participants should be better able to: Analyze results from genetic testing that may be used to incorporate precision medicine strategies into diagnostic, prognostic, and therapeutic algorithms for patients with hematologic malignanciesDefine mechanisms of action of current and emerging agents for hematologic malignanciesAssess recent and ongoing clinical trial data for existing and novel therapeutics for hematologic malignanciesFormulate evidence-based management strategies for sub-populations with hematologic malignancies (eg, older patients, who is with poor functional capacity)Identify an appropriate sequence of optimal agents for patients with refractory or relapsed hematological malignanciesEvaluate approaches that can be used to improve practice as an interdisciplinary healthcare team to provide better care to patients with hematologic malignanciesCongress Chair Morton Coleman, MD Co-Chair, Lymphoma Session John P. Leonard, MD Co-Chair, Myeloma Session Ruben Niesvizky, MD Co-Chair, CLL Session Richard R. Furman, MD Co-Chair, Acute Leukemia and Hematologic Malignancies Session Gail J. Roboz, MD Please visit lymphomamyeloma.com for full agenda and accreditation details
7:00am to 7:00pm
Sheraton New York Times Square Hotel
The 2018 Mark S. Brower, M.D. Lecture in Hematology and Oncology presents: Carl H. June, M.D. Richard W. Vague Professor in Immunotherapy Professor of Pathology and Laboratory Medicine Director, Center for Cellular Immunotherapies Director, Parker Institute for Cancer Immunotherapy Perelman School of Medicine University of Pennsylvania
11:00am to 7:00pm
Uris Auditorium Uris Auditorium
Join us on October 17-20, 2018 for the 18th annual Lymphoma & Myeloma Congress. This program features four days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders. Target Audience This educational activity is designed for domestic and international healthcare clinicians, including hematologists and hematologic oncologists, medical, radiation, and surgical oncologists, and other healthcare professionals (physicians, physicians-in-training, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) who are involved and/or interested in the treatment of patients with hematologic malignancies. Learning Objectives Upon successful completion of these educational activities, participants should be better able to: Analyze results from genetic testing that may be used to incorporate precision medicine strategies into diagnostic, prognostic, and therapeutic algorithms for patients with hematologic malignanciesDefine mechanisms of action of current and emerging agents for hematologic malignanciesAssess recent and ongoing clinical trial data for existing and novel therapeutics for hematologic malignanciesFormulate evidence-based management strategies for sub-populations with hematologic malignancies (eg, older patients, who is with poor functional capacity)Identify an appropriate sequence of optimal agents for patients with refractory or relapsed hematological malignanciesEvaluate approaches that can be used to improve practice as an interdisciplinary healthcare team to provide better care to patients with hematologic malignanciesCongress Chair Morton Coleman, MD Co-Chair, Lymphoma Session John P. Leonard, MD Co-Chair, Myeloma Session Ruben Niesvizky, MD Co-Chair, CLL Session Richard R. Furman, MD Co-Chair, Acute Leukemia and Hematologic Malignancies Session Gail J. Roboz, MD Please visit lymphomamyeloma.com for full agenda and accreditation details
7:00am to 7:00pm
Sheraton New York Times Square Hotel
Biochemistry and Cell & Developmental Biology Lecturer: Michael Hoppa, Ph.D. Assistant Professor Dartmouth College
12:00pm to 1:00pm
WCM A106
Join us on October 17-20, 2018 for the 18th annual Lymphoma & Myeloma Congress. This program features four days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders. Target Audience This educational activity is designed for domestic and international healthcare clinicians, including hematologists and hematologic oncologists, medical, radiation, and surgical oncologists, and other healthcare professionals (physicians, physicians-in-training, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) who are involved and/or interested in the treatment of patients with hematologic malignancies. Learning Objectives Upon successful completion of these educational activities, participants should be better able to: Analyze results from genetic testing that may be used to incorporate precision medicine strategies into diagnostic, prognostic, and therapeutic algorithms for patients with hematologic malignanciesDefine mechanisms of action of current and emerging agents for hematologic malignanciesAssess recent and ongoing clinical trial data for existing and novel therapeutics for hematologic malignanciesFormulate evidence-based management strategies for sub-populations with hematologic malignancies (eg, older patients, who is with poor functional capacity)Identify an appropriate sequence of optimal agents for patients with refractory or relapsed hematological malignanciesEvaluate approaches that can be used to improve practice as an interdisciplinary healthcare team to provide better care to patients with hematologic malignanciesCongress Chair Morton Coleman, MD Co-Chair, Lymphoma Session John P. Leonard, MD Co-Chair, Myeloma Session Ruben Niesvizky, MD Co-Chair, CLL Session Richard R. Furman, MD Co-Chair, Acute Leukemia and Hematologic Malignancies Session Gail J. Roboz, MD Please visit lymphomamyeloma.com for full agenda and accreditation details
7:00am to 7:00pm
Sheraton New York Times Square Hotel
Join us on October 17-20, 2018 for the 18th annual Lymphoma & Myeloma Congress. This program features four days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders. Target Audience This educational activity is designed for domestic and international healthcare clinicians, including hematologists and hematologic oncologists, medical, radiation, and surgical oncologists, and other healthcare professionals (physicians, physicians-in-training, oncology nurses, nurse practitioners, pharmacists, physician assistants, etc.) who are involved and/or interested in the treatment of patients with hematologic malignancies. Learning Objectives Upon successful completion of these educational activities, participants should be better able to: Analyze results from genetic testing that may be used to incorporate precision medicine strategies into diagnostic, prognostic, and therapeutic algorithms for patients with hematologic malignanciesDefine mechanisms of action of current and emerging agents for hematologic malignanciesAssess recent and ongoing clinical trial data for existing and novel therapeutics for hematologic malignanciesFormulate evidence-based management strategies for sub-populations with hematologic malignancies (eg, older patients, who is with poor functional capacity)Identify an appropriate sequence of optimal agents for patients with refractory or relapsed hematological malignanciesEvaluate approaches that can be used to improve practice as an interdisciplinary healthcare team to provide better care to patients with hematologic malignanciesCongress Chair Morton Coleman, MD Co-Chair, Lymphoma Session John P. Leonard, MD Co-Chair, Myeloma Session Ruben Niesvizky, MD Co-Chair, CLL Session Richard R. Furman, MD Co-Chair, Acute Leukemia and Hematologic Malignancies Session Gail J. Roboz, MD Please visit lymphomamyeloma.com for full agenda and accreditation details
7:00am to 7:00pm
Sheraton New York Times Square Hotel
Join Weill Cornell Medicine and the 5 Under 40 Foundation for the Young Women's Breast Cancer Survivorship Symposium. Topics will include resilience, nutrition, exercise, fertility and more. Speakers Tessa Cigler, MD, MPH Weill Cornell Breast Center Guy Maytal, MD Weill Cornell Psychiatry Collaborative Care Center Alexis Melnick, MD Weill Cornell Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Katherine Saunders, MD Weill Cornell Medicine Comprehensive Weight Control Center Leticia Varella, MD Weill Cornell Breast Center Breakfast and lunch will be served at this free event.
9:30am to 2:00pm
Weill Greenberg Center 2nd Floor Conference Rooms
Biochemistry and Cell & Developmental Biology Lecturer: Chris Fromme, Ph.D., Associate Professor, Dept. of Molecular Biology & Genetics Cornell U. - ITHACA Host: Dr. Frederick Maxfield Please call 646.962.2759 for more information.
12:00pm to 1:00pm
Weill Cornell Medical College A106